“Regulatory Affairs Is No Longer Just Compliance, it’s Strategy.”
That perspective perfectly captures the insights shared by Kiran Khan, Manager, Regulatory Affairs at Kymera Therapeutics, in the latest episode of the Life Sciences – In Focus podcast.
As drug development becomes increasingly complex, regulatory affairs professionals are stepping into more strategic roles than ever before. From navigating accelerated approval pathways to leveraging artificial intelligence responsibly, Kiran offers a thoughtful and practical perspective on the future of regulatory affairs and the skills professionals will need to succeed. The discussion explored the evolution of regulatory strategy, global harmonization, health authority engagement, and why curiosity remains one of the most valuable traits in the profession.
From Pharmacy School to Regulatory Affairs: Finding the Perfect Intersection
Like many regulatory professionals, Kiran did not set out to pursue a lifelong career in regulatory affairs. Her academic journey included studies in microbiology, psychology, and pharmacy, driven by a passion for both science and the human side of healthcare. It was during pharmacy school that she discovered regulatory affairs through conversations with industry fellows who described the role as a unique blend of science, medicine, strategy, and patient access.
That introduction sparked a career path that ultimately led her to pursue internships and advanced studies in regulatory affairs. Today, Kiran sees the profession as one that rewards curiosity, problem-solving, communication, and a commitment to lifelong learning.
As she shared during the episode, no two days are ever the same. One day may involve evaluating clinical data, while the next focuses on manufacturing challenges or global regulatory strategy. That variety continues to make the field both intellectually stimulating and deeply impactful.
The Evolution of Regulatory Affairs: From Compliance to Strategic Leadership
One of the most significant changes Kiran has witnessed is the transformation of regulatory affairs from a function primarily focused on submissions and compliance into a strategic partner involved throughout the entire product lifecycle.
Historically, regulatory teams were often engaged near the end of development to ensure compliance and prepare submissions. Today, they are integrated much earlier, helping shape development plans, inform global market strategies, and guide organizations through uncertainty.
According to Kiran, the regulatory professional of the future will need to be more than a technical expert. They will be strategists, communicators, and trusted advisors who help organizations make informed decisions in increasingly complex development environments.
AI in Regulatory Affairs: Powerful Tool, Not a Replacement
Artificial intelligence continues to dominate conversations across the life sciences industry, and regulatory affairs is no exception.
Kiran believes AI has enormous potential to streamline regulatory processes by assisting with regulatory intelligence, identifying trends across guidance documents, and supporting document preparation. However, she emphasized that regulatory strategy remains fundamentally dependent on human judgment.
The regulatory landscape is filled with nuance, context, and risk-based decision-making that cannot be fully automated. AI can accelerate workflows and improve efficiency, but it cannot replace the critical thinking required to evaluate data, assess risk, and determine the best path forward for a product.
One practical application Kiran highlighted is using AI for quality control checks, helping teams identify inconsistencies or errors that might otherwise be overlooked during manual review.
As discussed during the episode, the future is not AI versus humans; it is AI combined with human expertise.
Accelerated Pathways Require Long-Term Thinking
As more biotech companies pursue expedited development and approval pathways, Kiran stressed the importance of maintaining a long-term perspective.
Accelerated programs enable the rapid introduction of innovative therapies to patients, particularly in areas of significant unmet medical need. However, obtaining approval is only one milestone in a much longer journey.
Successful regulatory strategies require:
- Early planning
- Cross-functional alignment
- Proactive health authority engagement
- Ongoing evidence generation
- Fulfillment of post-approval commitments
Kiran noted that organizations must think beyond initial approval and focus on demonstrating the long-term value and safety of therapies throughout their lifecycle.
Global Harmonization: Progress and Complexity
The globalization of drug development continues to create opportunities and challenges for regulatory teams.
While harmonization efforts have improved significantly over the years, regional differences remain a critical consideration. Different countries and regions maintain unique healthcare systems, priorities, and regulatory expectations.
As a result, regulatory professionals must balance the benefits of global alignment with the realities of local requirements.
Kiran emphasized that an effective global regulatory strategy requires both standardization and flexibility. Organizations must build development programs capable of supporting multiple markets while remaining agile enough to address regional nuances when necessary.
This balancing act is one of the reasons regulatory affairs remains such a fascinating and dynamic profession.
The Growing Importance of Communication
Throughout the conversation, one theme consistently emerged: communication.
According to Kiran, technical expertise alone is no longer sufficient. Regulatory professionals must also be exceptional communicators who can clearly articulate complex scientific and regulatory concepts to diverse stakeholders.
Whether engaging with health authorities, collaborating across functions, or building a compelling case around data, communication skills are becoming just as valuable as regulatory knowledge.
Since the COVID-19 pandemic, interactions with health authorities have evolved significantly. Many engagements now occur through written communication rather than face-to-face meetings. This shift has elevated the importance of concise, persuasive, and transparent communication.
The ability to tell a compelling story with data is increasingly becoming a defining characteristic of successful regulatory leaders.
Looking Ahead: The Future of the Profession
As Kiran looks toward the future, she sees continued evolution across regulatory affairs.
Key areas she is watching include:
- Artificial intelligence adoption
- Regulatory intelligence advancements
- Evolving global regulations
- New skills required for future regulatory professionals
- Greater strategic integration across organizations
She is particularly interested in how companies will implement AI technologies while preserving the human expertise required to make informed regulatory decisions.
Equally important are the informal conversations that occur within the regulatory community. Conferences such as the annual Regulatory Affairs Professionals Society (RAPS) Convergence provide valuable opportunities for professionals to exchange ideas, learn from one another, and build lasting relationships.
Stay Curious
When asked what message she would leave with listeners, Kiran’s answer was simple yet powerful:
Stay curious.
Science is constantly evolving. Regulations continue to change. New technologies are transforming how therapies are developed and approved. For regulatory professionals, learning never stops, and that is exactly what makes the field so rewarding.
As Kiran reminded listeners, curiosity fuels growth, encourages engagement, and opens doors to unexpected opportunities.
We couldn’t agree more.
About Life Sciences – In Focus
Life Sciences – In Focus Podcast by Visatatec, a fascinating conversation with global life sciences experts. The show has multiple hosts and topics. Follow Life Sciences – In Focus on Spotify for all the latest episodes, or subscribe to the show on YouTube and Apple podcasts. Life Sciences – In Focus is available on many other podcast platforms. To learn more about the podcast, please visit https://vistatec.com/life-sciences-division.
About Vistatec
We have been helping some of the world’s most iconic brands to optimize their global commercial potential since 1997. Vistatec is one of the world’s leading global content solutions providers. HQ in Dublin, Ireland, with offices in Mountain View, California, USA. To learn more about Vistatec, please visit https://www.vistatec.com